These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
447 related items for PubMed ID: 1941633
1. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol. Weissenburger J, Davy JM, Chézalviel F, Ertzbischoff O, Poirier JM, Engel F, Lainée P, Penin E, Motté G, Cheymol G. J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633 [Abstract] [Full Text] [Related]
2. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes. Chézalviel-Guilbert F, Davy JM, Poirier JM, Weissenburger J. J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874 [Abstract] [Full Text] [Related]
3. Combination of sotalol and quinidine in a canine model of torsades de pointes: no increase in the QT-related proarrhythmic action of sotalol. Chézalviel-Guilbert F, Deplanne V, Davy JM, Poirier JM, Xia YZ, Cheymol G, Weissenburger J. J Cardiovasc Electrophysiol; 1998 May; 9(5):498-507. PubMed ID: 9607458 [Abstract] [Full Text] [Related]
4. [Sotalol-induced torsades de pointe in the conscious dog with atrioventricular block. Role of hypokalemia]. Davy JM, Weissenburger J, Ertzbischoff O, Lainée P, Chezalviel F, Poirier JM, Cheymol G, Motte G. Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1117-24. PubMed ID: 3143334 [Abstract] [Full Text] [Related]
5. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L. J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304 [Abstract] [Full Text] [Related]
6. Proarrhythmic effects of a quinidine analog in dogs with chronic A-V block. Chézalviel-Guilbert F, Weissenburger J, Davy JM, Guhennec C, Poirier JM, Cheymol G. Fundam Clin Pharmacol; 1995 Jun; 9(3):240-7. PubMed ID: 7557819 [Abstract] [Full Text] [Related]
7. Experimental models of torsades de pointes. Weissenburger J, Davy JM, Chézalviel F. Fundam Clin Pharmacol; 1993 Jun; 7(1):29-38. PubMed ID: 8458600 [Abstract] [Full Text] [Related]
8. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs. Sen L, Cui G, Sakaguchi Y, Singh BN. J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614 [Abstract] [Full Text] [Related]
9. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies. Ducroq J, Printemps R, Guilbot S, Gardette J, Salvetat C, Le Grand M. J Pharmacol Toxicol Methods; 2007 May; 56(2):159-70. PubMed ID: 17604185 [Abstract] [Full Text] [Related]
10. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides. Gautam CS, Sharma PL, Pandhi P. Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201 [Abstract] [Full Text] [Related]
11. Comparative antiarrhythmic activity of quinidine combined with propranolol and with sotalol. Lawson JW, Wojciechowski NJ. Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):72-86. PubMed ID: 6111984 [Abstract] [Full Text] [Related]
13. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Vos MA, Verduyn SC, Gorgels AP, Lipcsei GC, Wellens HJ. Circulation; 1995 Feb 01; 91(3):864-72. PubMed ID: 7828315 [Abstract] [Full Text] [Related]
14. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation. van Brakel TJ, Hermans JJ, Accord RE, Schotten U, Smits JF, Allessie MA, Maessen JG. J Cardiovasc Electrophysiol; 2009 Feb 01; 20(2):207-15. PubMed ID: 19175851 [Abstract] [Full Text] [Related]
15. Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia. Fabritz L, Kirchhof P, Franz MR, Eckardt L, Mönnig G, Milberg P, Breithardt G, Haverkamp W. Basic Res Cardiol; 2003 Feb 01; 98(1):25-32. PubMed ID: 12494266 [Abstract] [Full Text] [Related]
16. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872. Bril A, Gout B, Bonhomme M, Landais L, Faivre JF, Linee P, Poyser RH, Ruffolo RR. J Pharmacol Exp Ther; 1996 Feb 01; 276(2):637-46. PubMed ID: 8632331 [Abstract] [Full Text] [Related]
17. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy]. Sarubbi B, Ducceschi V, Briglia N, Esposito R, Mayer MS, Scialdone A, Santangelo L, Iacono A. Cardiologia; 1996 Jul 01; 41(7):645-51. PubMed ID: 8983831 [Abstract] [Full Text] [Related]
18. Comparative study on the proarrhythmic effects of some antiarrhythmic agents. Dhein S, Müller A, Gerwin R, Klaus W. Circulation; 1993 Feb 01; 87(2):617-30. PubMed ID: 8425305 [Abstract] [Full Text] [Related]
19. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol. Fiset C, Drolet B, Hamelin BA, Turgeon J. J Pharmacol Exp Ther; 1997 Oct 01; 283(1):148-56. PubMed ID: 9336319 [Abstract] [Full Text] [Related]
20. Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes. Farkas A, Leprán I, Papp JG. J Cardiovasc Pharmacol; 2002 Feb 01; 39(2):287-97. PubMed ID: 11791015 [Abstract] [Full Text] [Related] Page: [Next] [New Search]